1. All Products
  2. DVACVTYP - Vaccine Typhoid
  3. VACCINE TYPHOID CONJUGATE, 1 dose, multid. vial
Public Pricelist

VACCINE TYPHOID CONJUGATE, 1 dose, multid. vial

https://medicalguidelines.msf.org/en/node/984#id-.SicklecelldiseasevEnglish-Routinepreventivecare
https://unicat.msf.org/cat/product/74335
STD DVACVTYPC1VD

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07AP03
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VACCINE TYPHOID conjugate

CAUTION

The multidose vaccine is worded and codified by unit (= 1 dose) to make the order easier.

Therapeutic Action

Typhoid Vi conjugate vaccine

Indications

Active immunisation against typhoid fever in adults and children from 6 months of age.

The typhoid conjugate vaccine (TCV) offers a broader age range (can be administered from the age of 6 months) and longer-lasting protection (probably several years) than the typhoid unconjugate polysaccharide vaccine administered from the age of 2 years, with protection for 2 years.

The conjugate vaccine should replace the polysaccharide unconjugate vaccine.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Suspension in liquid form. Shake well before use to homogenise the suspension.

Must be given as IM injection in the anterolateral aspect of thigh or upper arm (deltoid), on a one-dose schedule.

The multidose vial is more suitable for programme use and/or mass vaccination campaigns.

Orders are always done in number of doses and not in number of vials! (See Preliminary remarks on Vaccines)

The monodose vial is intended for staff vaccination. This presentation will reduce the wastage and reluctance to open a multi-dose vial if the number of people to be vaccinated is too low.

Precautions for Use

Do not administer into the gluteal muscle.

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC
  • Do not freeze.
  • Opened vials: store between 2°C and 8°C for up to 6 hrs.
  • The vaccine vial monitor (VVM) is mandatory on each vaccine.

(Cf Introduction: Thermosensitive products)